The purposes of our study were to generate a comprehensive proteomic map of AG, NAG and metastatic PCa by using a DIA approach and to identify unique AG-associated proteins, which might be used for the development of a clinical assay to separate AG from NAG PCa. This evidence concerns the gene RENBP and posterior cortical atrophy.